AllDocs -> cancers

3 rd Annual Uterine Cancer Biology Symposium Strategies in the Management of Uterine Papillary Serous, Malignant Mullerian Tumor, and Clear Cell Carcinoma Saturday May 13, 2006 The Farrell Learning and Teaching Center, St. Louis Course Co-Chairs Russell R. Broaddus, M.D, Ph.D. Karen H. Lu, M.D. David G. Mutch, M.D. Jointly-Sponsored By Washington University School of Medicine Continuing Medical Education and M.D. Anderson Cancer Center Gynecologic Oncology Presented By Page 2 COURSE OBJECTIVES This activity is designed for gynecologic oncologists, radiation oncologists, gynecologic pathologists, medical oncologists, research scientists, nurses, fellows, residents and students. The goal of the symposium is to explore novel approaches in the prevention ...

Kuv Yuav Ceev Faj Txog Yam Dabtsi? Paub koj lub cev kom zoo. Yog koj paub los yog mloog tau hais tias muaj qhov txawv los pauv nyob hauv koj lub cev thiab qhia koj tus kws khomob, kws khomob yuav nrhiav tau tus kabmob ntxov. Yog nrhiav tau tus kabmob kheesxws ntxov, nws yuav ua txoj kev kho tus kabmob ntawd yooj yim dua. Koj yuav tsum qhia tej yam li hauv qab no rau koj tus kws khomob sai li sai tau: Los ntshav uas tsis yog koj coj khaub ncaws; Muaj tej yam dabtsi tawm hauv koj qhov chaw mos los, tom qab uas koj tsis coj khaub ncaws lawm; Tsam los yog mob ntawm koj lub plab mog; Qhov koj hnyav nce los poob uas tsi paub yog vim dabtsi; Muaj qog nyob ib ncig ntawm koj lub plab mog. Cov poj niam uas muaj txoj kev kho hu ua estrogen replacement therapy yuav tsum qhia lawv tus kws khomob sai li sai tau yog lawv muaj tej yam li hauv qab no: Los ntshav los yog pom ntshav ...

? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? • ? ? ? ? ? ? • ? ? • ? ? ? ? ? ? ? ? ?(? ? ?)? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? • ? ? ? ? ? • ()? • ? ? ?(? ?)? • ? • ? ? ? ? • ? ? ? ? ? ? ...

Cancer Therapy Vol 3, page 419 419 Cancer Therapy Vol 3, 419-434, 2005 Implications of HPV infection in uterine cervical cancer Review Article Hoenil Jo, Jae Weon Kim* Department of Obstetrics and Gynecology, Cancer Research Institute, Seoul National University, Seoul, Korea _ *Correspondence: Jae Weon Kim, Department of Obstetrics and Gynecology and Cancer Research Institute, Seoul National University Hospital, 28 Yongon-dong, Seoul, Korea; Tel: 82 2 2072 3511; Fax: 82 2 762 3599; e-mail: kjwksh@snu.ac.kr Key words: Human papillomavirus, Cervical cancer , Molecular pathophysiology, Co-factors, HPV vaccine Abbreviations: 21-kDa protein, (p21); activating protein 1, (AP 1); arginine, (ARG); cyclin/cyclin dependent kinase, (cdk); double minute 2 gene, (MDM2); E6-associated protein, (E6AP); early, (E); late, (L); long control region, (LCR); nuclear factor 1, (NF-I); ...

Age Sex Site Diagnosis pTNM Stage 1 70 F cervix squamous cell carcinoma T1aN0M0 I 2 46 F cervix squamous cell carcinoma T1a1N0M0 IA1 3 42 F cervix microinvasive squamous cell carcinoma T1a1N0M0 IA1 4 57 F cervix squamous cell carcinoma in situ TisN0M0 0 5 33 F cervix microinvasive squamous cell carcinoma T1a1N0M0 IA1 6 35 F cervix squamous cell carcinoma in situ TisN0M0 0 7 48 F cervix microinvasive squamous cell carcinoma T1a1N0M0 IA1 8 39 F cervix microinvasive squamous cell carcinoma T1N0M0 I 9 58 F cervix microinvasive squamous cell carcinoma T1N0M0 I 10 53 F cervix squamous cell carcinoma in situ TisN0M0 ...

Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer Dong Choon Park, a,1 Jae Hoon Kim, a Young Ok Lew, a Dae Hoon Kim, a, * and Sung Eun Namkoong b a Department of Obstetrics and Gynecology, Saint Vincent’s Hospital, The Catholic University of Korea, Suwon, Korea b Kang Nam Saint Mary’s Hospital, The Catholic University of Korea, Seoul, Korea Received 20 November 2002 Abstract Objectives . The toxicity and effectivity of intravenous paclitaxel and cisplatin as neoadjuvant chemotherapy were assessed in cervical cancer patients. Patients and methods . Forty-three consecutive patients affected by International Federation of Gynecology and Obstetrics (FIGO) stage IB2 to IIB were treated with paclitaxel 60 mg/m 2 that was administered intravenously over ...

Survival prediction using artificial neural networks in patients with uterine cervical cancer Masahiro Iinuma, Kenya Murase Department of Medical Physics and Engineering, Graduate School of Medicine, Osaka University, Osaka, Japan Abstract Our purpose of this study was to construct the predict model using artificial neural networks (ANNs) from radiation oncology database. Although there is no guarantee that trained ANNs models reached an error minimum point, we made 40 models by each combination of hidden nodes (30, 50, 100, and 150). Using the trained ANNs, we predicted the survival in patients with uterine cervical cancer treated by radiation therapy. The performance of ANNs was evaluated using receiver operating characteristic (ROC) analysis by those maximums and the mean. Az value was the highest at the number of neuron 150, and the value was maximum ...

UTERINE CANCER OVERVIEW THE FEMALE REPRODUCTIVE SYSTEM DESCRIPTION Uterine cancer (endometrial cancer ) is a malignancy of the uterus , found in women. It affects the lining of the uterus (endometrium). Uterine cancer is most often a type of cancer called an adenocarcinoma . It is the most commonly diagnosed cancer of the female reproductive system . Other names sometimes used for uterine cancer are cancer of the uterus, endometrial cancer , endometrial carcinoma , cancer of the uterine corpus , or cancer of the uterine body. Two other types of cancer that occur in the uterus are different from endometrial cancer . They are cancers of the cervix , which most often affects the surface cells (squamous cells) lining the cervix, and uterine sarcoma, which affects the muscle layer of the uterus (myometrium). Uterine sarcoma is rare (2%-5% of all cancers found ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN UTERINE CERVIX CANCER TISSUE MICROARRAY Catalog Number: TMA-005 Each core represents one specimen selected and pathologically confirmed. Normal matched or unmatched uterine cervix tissue is provided for comparison to the cancer tissue. Cases : 68 Cores : 80 Diameter : 1.5 mm Thickness: 5 µm Standard IHC: Cytokeratin confirmed Layout : 8 x 10 1 2 3 4 5 6 7 8 9 10 A 1 2 3 4 5 6 7 8 9 10 B 11 12 13 14 15 16 17 18 19 20 C 21 22 23 24 25 26 27 28 29 30 ...

Endometrial ( Uterine ) Cancer This material is intended for insurance informational purposes only and is not personal medical advice for clients. This marketing material includes an expiration date and use of this material must be discontinued as of the expiration date. FOR INTERNAL USE ONLY. NOT FOR USE WITH THE PUBLIC ©2005 The Prudential Insurance Company of America 751 Broad Street, Newark, NJ 07102-3777 Rx060 IFS-A018915 Ed. 10/05 Exp. 04/07 Endometrial ( uterine ) cancer is diagnosed in almost 39,300 women/year in the U.S. Although cancer death rates have been declining since the 1930’s due primarily to earlier diagnosis, endometrial cancer still accounts for approximately 6,600 cancer deaths each year. It occurs most frequently in women between the ages of 50 and 70. Risk Factors for endometrial cancer inlude: o menstrual irregularities o never being pregnant ...

uterine cancer News Release Penn State College of Medicine Tel: (717) 531-8606 Penn State Milton S. Hershey Medical Center Fax: (717) 531-6999 Strategic Services, A140 600 Centerview Drive P.O. Box 855 Hershey, PA 17033-0855 FOR IMMEDIATE RELEASE MEDIA INQUIRIES CONTACT: Mon., Jan. 2, 2006 Megan Walde Manlove (717) 531-8604 mmanlove@hmc.psu.edu PENN STATE PHYSICIAN TESTING POTENTIAL SCREENING ...

Web Immagini Gruppi Directory News altro » Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:kGbaja8uC-YJ:www.uhce.ox.ac.uk/Epidembase2/atlases/condition_2a/Uterine%20cancer_final.pdf allintitle: uterine cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: Assicurarsi che tutte le parole siano state digitate correttamente. Provare con parole chiave diverse. Provare con parole chiave più generiche. Provare ...

1 UTERINE CANCER What is Uterine Cancer ? The uterus (also known as the womb) is an organ in the middle of the female pelvis. The uterus is where the fertilized egg implants and growth and development of the baby occurs. The uterus is basically a large hollow muscle. During a woman’s labor, the uterus contracts and causes the baby to be born. In women of childbearing age, the lining of the uterus sheds every month in response to the ovarian hormones, estrogen and progesterone, in a process known as menstruation. At menopause, or change in life, the production of these hormones decreases and menstruation stops. Vaginal bleeding after menopause is considered abnormal. Page 2 2 Uterine cancer is a disease in which cancer cells are found in either the lining (endometrium) or the wall (stroma and myometrium) of the uterus. Cancers of the lining ...

Web Immagini Gruppi Directory News altro » Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:GeVGxBZc6REJ:www.houstongynonc.com/resources/website%20uterine%20cancer.pdf allintitle: uterine cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: Assicurarsi che tutte le parole siano state digitate correttamente. Provare con parole chiave diverse. Provare con parole chiave più generiche. Provare con un numero ...

Web Immagini Gruppi Directory News altro » Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:Im2xGD9ueTQJ:www.dhs.ca.gov/director/owh/owh_main/gcip/languages/english/WEB_UC.pdf allintitle: uterine cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: Assicurarsi che tutte le parole siano state digitate correttamente. Provare con parole chiave diverse. Provare con parole chiave più generiche. Provare con ...

UTERINE CANCER IN MARIN COUNTY 1995-1999 0 5 10 15 20 25 30 35 40 45 Marin SF Bay Area Urban CA Incidence Mortality * In general, corpus uteri cancer is more common among women of white non-Hispanic ethnicity than among women of other ethnicities. The small size of the African-American, Hispanic, and Asian populations in Marin County prevents the calculation of stable incidence rates for these populations. For this reason, and because the incidence of corpus uteri cancer varies by race/ethnicity, the above data includes only white non-Hispanic Marin County residents. Age-adjusted rates of corpus uteri cancer among individuals of white-non- Hispanic race/ethnicity, 1995-1999: Incidence Rates: Marin: 34.4/100,000 San Francisco Bay Area: 26.6/100,000 Urban California: ...

Uterine cancer The uterus (womb) is part of the female reproductive system. It is shaped like an upside down pear and sits inside the pelvis. It is in the uterus that a fertilised egg grows into a baby. Over 470 Victorian women are diagnosed with cancer of the uterus every year. Most of these women are over the age of 50 years. Cancer of the uterus is also known as cancer of the womb, uterine cancer, endometrial cancer and cancer of the lining of the womb. Different types Most cases of cancer of the uterus are cancers of the uterus lining (endometrium), though some cancers grow in the muscle layers of the uterus. The different types of uterine cancer include: • Adenocarcinoma of the endometrium - around 85 per cent of women diagnosed with cancer of the uterus have this form. An adenocarcinoma is a cancer that starts in ...

What Should I Look For? Know what is normal for your body. If you notice changes in your body and tell the doctor, the disease may be found earlier. Finding cancer of the uterus early makes it easier to treat. You should report any of the following signs to your doctor right away: Bleeding that is not your normal period; Discharge from the vagina, especially after you have stopped having periods (menopause); Bloating or cramping in your pelvis; Unintentional weight loss or gain; A lump in your pelvis. Women who take estrogen replacement therapy should report any of the following to their doctor immediately: Bleeding or spotting after sex; Bleeding that lasts longer than 7 days; Periods that come every 21 days or less; Bleeding or staining after six months or more of no bleeding at all (menopause). What Adds to My Risk? Estrogen is a hormone ...